Statement of Ownership (sc 13g)
31 Dezember 2014 - 10:03PM
Edgar (US Regulatory)
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
|
OMB Number:3235-0145
Expires: February 28, 2009
Estimated average burden
hours per response… 10.4
|
|
|
SCHEDULE 13G
|
|
|
Under the Securities Exchange Act of 1934
|
|
|
(Amendment No. ___)*
|
|
|
Ardelyx, Inc.
|
|
|
(Name of Issuer)
|
|
|
Common Stock, $0.0001 par value
|
|
|
(Title of Class of Securities)
|
|
|
December 23, 2014
|
|
|
(Date of Event which Requires Filing of this Statement)
|
|
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[ ] Rule 13d-1(b)
[x] Rule 13d-1(c)
[ ] Rule 13d-1(d)
___________________________________
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Global Healthcare Master Fund, LP
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
|
(b) [x]
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization.
Cayman Islands
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
6 Shared Voting Power
952,000 shares (1,003,500 shares as of the filing date)
Refer to Item 4 below.
|
7 Sole Dispositive Power
0 shares
|
8 Shared Dispositive Power
952,000 shares (1,003,500 shares as of the filing date)
Refer to Item 4 below.
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
952,000 shares (1,003,500 shares as of the filing date)
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
5.13% (5.41% as of the filing date)
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
PN (Partnership)
|
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Global Healthcare GP, LLC
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
|
(b) [x]
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization.
Delaware
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
6 Shared Voting Power
952,000 shares (1,003,500 shares as of the filing date)
Refer to Item 4 below.
|
7 Sole Dispositive Power
0 shares
|
8 Shared Dispositive Power
952,000 shares (1,003,500 shares as of the filing date)
Refer to Item 4 below.
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
952,000 shares (1,003,500 shares as of the filing date)
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
5.13% (5.41% as of the filing date)
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
OO (Limited Liability Company)
|
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Asset Management, LLC
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
|
(b) [x]
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization.
Delaware
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
6 Shared Voting Power
952,000 shares (1,003,500 shares as of the filing date)
Refer to Item 4 below.
|
7 Sole Dispositive Power
0 shares
|
8 Shared Dispositive Power
952,000 shares (1,003,500 shares as of the filing date)
Refer to Item 4 below.
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
952,000 shares (1,003,500 shares as of the filing date)
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
5.13% (5.41% as of the filing date)
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
OO (Limited Liability Company)
|
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Bihua Chen
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
|
(b) [x]
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization.
United States
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
6 Shared Voting Power
952,000 shares (1,003,500 shares as of the filing date)
Refer to Item 4 below.
|
7 Sole Dispositive Power
0 shares
|
8 Shared Dispositive Power
952,000 shares (1,003,500 shares as of the filing date)
Refer to Item 4 below.
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
952,000 shares (1,003,500 shares as of the filing date)
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
5.13% (5.41% as of the filing date)
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
IN (Individual)
|
|
(a)
|
Name of Issuer
|
|
Ardelyx, Inc.
|
(b)
|
Address of Issuer’s Principal Executive Offices
|
|
34175 Ardenwood Blvd.
Fremont, California 94555
|
(a)
|
Name of Person Filing
|
|
Cormorant Global Healthcare Master Fund, LP
Cormorant Global Healthcare GP, LLC
Cormorant Asset Management, LLC
Bihua Chen
|
(b)
|
Address of Principal Business Office or, if none, Residence
|
|
100 High Street, Suite 1105
Boston, MA 02110
|
(c)
|
Citizenship
|
|
Cormorant Global Healthcare Master Fund, LP - Cayman Islands
Cormorant Global Healthcare GP, LLC - Delaware
Cormorant Asset Management, LLC - Delaware
Bihua Chen - United States
|
(d)
|
Title of Class of Securities
|
|
Common Stock
|
(e)
|
CUSIP Number
|
|
039697107
|
Item 3.
|
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
(a)
|
[ ]
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
(b)
|
[ ]
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
(c)
|
[ ]
|
Insurance Company as defined in Section 3(a)(19) of the Act
|
(d)
|
[ ]
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
(e)
|
[ ]
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
(f)
|
[ ]
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
(g)
|
[ ]
|
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
(h)
|
[ ]
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
(i)
|
[ ]
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
(j)
|
[ ]
|
A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
|
(k)
|
[ ]
|
Group, in accordance with §240.13d-1(b)(1)(ii)(K).
|
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a)
|
Amount Beneficially Owned***
|
|
Cormorant Global Healthcare Master Fund, LP - 952,000 shares (1,003,500 shares as of the filing date)
Cormorant Global Healthcare GP, LLC - 952,000 shares (1,003,500 shares as of the filing date)
Cormorant Asset Management, LLC - 952,000 shares (1,003,500 shares as of the filing date)
Bihua Chen - 952,000 shares (1,003,500 shares as of the filing date)
|
(b)
|
Percent of Class
|
|
Cormorant Global Healthcare Master Fund, LP - 5.13% (5.41% as of the filing date)
Cormorant Global Healthcare GP, LLC - 5.13 % (5.41% as of the filing date)
Cormorant Asset Management, LLC - 5.13% (5.41% as of the filing date)
Bihua Chen - 5.13% (5.41% as of the filing date)
|
(c)
|
Number of shares as to which such person has:
|
|
(i)
|
sole power to vote or to direct the vote
|
|
|
Cormorant Global Healthcare Master Fund, LP - 0 shares
Cormorant Global Healthcare GP, LLC - 0 shares
Cormorant Asset Management, LLC - 0 shares
Bihua Chen - 0 shares
|
|
(ii)
|
shared power to vote or to direct the vote
|
|
|
Cormorant Global Healthcare Master Fund, LP - 952,000 shares (1,003,500 shares as of the filing date)
Cormorant Global Healthcare GP, LLC - 952,000 shares (1,003,500 shares as of the filing date)
Cormorant Asset Management, LLC - 952,000 shares (1,003,500 shares as of the filing date)
Bihua Chen - 952,000 shares (1,003,500 shares as of the filing date)
|
|
(iii)
|
sole power to dispose or to direct the disposition of
|
|
|
Cormorant Global Healthcare Master Fund, LP - 0 shares
Cormorant Global Healthcare GP, LLC - 0 shares
Cormorant Asset Management, LLC - 0 shares
Bihua Chen - 0 shares
|
|
(iv)
|
shared power to dispose or to direct the disposition of
|
|
|
Cormorant Global Healthcare Master Fund, LP - 952,000 shares (1,003,500 shares as of the filing date)
Cormorant Global Healthcare GP, LLC - 952,000 shares (1,003,500 shares as of the filing date)
Cormorant Asset Management, LLC - 952,000 shares (1,003,500 shares as of the filing date)
Bihua Chen - 952,000 shares (1,003,500 shares as of the filing date)
|
*** Shares reported herein represent shares that may be deemed beneficially owned by Cormorant Global Healthcare Master Fund, LP (the “Fund”). Cormorant Global Healthcare GP, LLC serves as the general partner of the Fund, and Cormorant Asset Management, LLC serves as the investment manager of the Fund. Bihua Chen serves as the managing member of Cormorant Global Healthcare GP, LLC and Cormorant Asset Management, LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.
Item 5.
|
Ownership of Five Percent or Less of a Class
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person
|
Not applicable.
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
|
Not applicable.
Item 8.
|
Identification and Classification of Members of the Group
|
Not applicable.
Item 9.
|
Notice of Dissolution of Group
|
Not applicable.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.
December 31, 2014
CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP
By: Cormorant Global Healthcare GP, LLC
its General Partner
By: /s/ Bihua Chen
Bihua Chen, Managing Member
CORMORANT GLOBAL HEALTHCARE GP, LLC
By: /s/ Bihua Chen
Bihua Chen, Managing Member
CORMORANT ASSET MANAGEMENT, LLC
By: /s/ Bihua Chen
Bihua Chen, Managing Member
/s/ Bihua Chen
Exhibit 1
JOINT FILING AGREEMENT
This Joint Filing Agreement, dated as of December 31, 2014, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen (collectively, the "Filers").
Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13D and/or 13G with respect to shares of Common Stock of Ardelyx, Inc. beneficially owned by them from time to time.
Pursuant to and in accordance with Rule 13(d)(1)(k) promulgated under the Securities Exchange Act of 1934, as amended, the Filers hereby agree to file a single statement on Schedule 13D and/or 13G (and any amendments thereto) on behalf of each of the Filers, and hereby further agree to file this Joint Filing Agreement as an exhibit to such statement, as required by such rule.
This Joint Filing Agreement may be terminated by any of the Filers upon written notice or such lesser period of notice as the Filers may mutually agree.
Executed and delivered as of the date first above written.
CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP
By: Cormorant Global Healthcare GP, LLC
its General Partner
By: /s/ Bihua Chen
Bihua Chen, Managing Member
CORMORANT GLOBAL HEALTHCARE GP, LLC
By: /s/ Bihua Chen
Bihua Chen, Managing Member
CORMORANT ASSET MANAGEMENT, LLC
By: /s/ Bihua Chen
Bihua Chen, Managing Member
/s/ Bihua Chen
Bihua Chen
Ardelyx (NASDAQ:ARDX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Ardelyx (NASDAQ:ARDX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024